DEA Reviews Patheon API Services Application for Bulk Manufacturing of Psychedelic and Schedule II Substanc
April 18, 2025
April 18, 2025
WASHINGTON, April 18 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration (DEA) has published a notice announcing that Patheon API Services Inc., located in Florence, South Carolina, has applied for registration as a bulk manufacturer of several Schedule I and Schedule II controlled substances.
The substances include Dimethyltryptamine, Psilocybin, Psilocyn, Amphetamine, and Methadone. The application, submitted on February 5, 2025, is currently under review, a . . .
The substances include Dimethyltryptamine, Psilocybin, Psilocyn, Amphetamine, and Methadone. The application, submitted on February 5, 2025, is currently under review, a . . .